Literature DB >> 22454522

Fos plays an essential role in the upregulation of RANK expression in osteoclast precursors within the bone microenvironment.

Atsushi Arai1, Toshihide Mizoguchi, Suguru Harada, Yasuhiro Kobayashi, Yuko Nakamichi, Hisataka Yasuda, Josef M Penninger, Kazuhiro Yamada, Nobuyuki Udagawa, Naoyuki Takahashi.   

Abstract

Fos plays essential roles in the osteoclastic differentiation of precursor cells generated by colony-stimulating factor 1 (CSF-1) and receptor activator of NF-κB ligand (RANKL; also known as tumor necrosis factor ligand superfamily member 11, Tnsf11). RANKL-deficient (RANKL(-/-)) mice and Fos(-/-) mice exhibit osteopetrosis due to an osteoclast deficiency. We previously reported that RANK-positive osteoclast precursors are present in bone of RANKL(-/-) mice but not Fos(-/-) mice. Here we report the role of Fos in RANK expression in osteoclast precursors. Medullary thymic epithelial cells and intestinal antigen-sampling microfold cells have been shown to express RANK. High expression of RANK was observed in some epithelial cells in the thymic medulla and intestine but not in osteoclast precursors in Fos(-/-) mice. RANK mRNA and protein levels in bone were lower in Fos(-/-) mice than RANKL(-/-) mice, suggesting that Fos-regulated RANK expression is tissue specific. When wild-type bone marrow cells were inoculated into Fos(-/-) mice, RANK-positive cells appeared along bones. RANK expression in wild-type macrophages was upregulated by coculturing with RANKL(-/-) osteoblasts as well as wild-type osteoblasts, suggesting that cytokines other than RANKL expressed by osteoblasts upregulate RANK expression in osteoclast precursors. CSF-1 receptor-positive cells were detected near CSF-1-expressing osteoblastic cells in bone in Fos(-/-) mice. CSF-1 upregulated RANK expression in wild-type macrophages but not Fos(-/-) macrophages. Overexpression of Fos in Fos(-/-) macrophages resulted in the upregulation of RANK expression. Overexpression of RANK in Fos(-/-) macrophages caused RANKL-induced signals, but failed to recover the RANKL-induced osteoclastogenesis. These results suggest that Fos plays essential roles in the upregulation of RANK expression in osteoclast precursors within the bone environment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22454522     DOI: 10.1242/jcs.099986

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  34 in total

1.  Serum microRNA is a promising biomarker for osteogenesis imperfecta.

Authors:  Ziqiang Wang; Yanqin Lu; Xiumei Zhang; Xiuzhi Ren; Yanzhou Wang; Zhiliang Li; Chao Xu; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2012-05

2.  Alpha-1 antitrypsin inhibits RANKL-induced osteoclast formation and functions.

Authors:  Mohammad Ahsanul Akbar; David Nardo; Mong-Jen Chen; Ahmed S Elshikha; Rubina Ahamed; Eslam M Elsayed; Claire Bigot; Lexie Shannon Holliday; Sihong Song
Journal:  Mol Med       Date:  2017-03-21       Impact factor: 6.354

3.  The MET/Vascular Endothelial Growth Factor Receptor (VEGFR)-targeted Tyrosine Kinase Inhibitor Also Attenuates FMS-dependent Osteoclast Differentiation and Bone Destruction Induced by Prostate Cancer.

Authors:  Kenta Watanabe; Michiko Hirata; Tsukasa Tominari; Chiho Matsumoto; Hidenori Fujita; Kazuhiko Yonekura; Gillian Murphy; Hideaki Nagase; Chisato Miyaura; Masaki Inada
Journal:  J Biol Chem       Date:  2016-08-18       Impact factor: 5.157

4.  Cyclolinopeptide F, a cyclic peptide from flaxseed inhibited RANKL-induced osteoclastogenesis via downergulation of RANK expression.

Authors:  Toshio Kaneda; Yuki Nakajima; Sae Koshikawa; Alfarius Eko Nugroho; Hiroshi Morita
Journal:  J Nat Med       Date:  2019-03-15       Impact factor: 2.343

5.  Meckel's cartilage breakdown offers clues to mammalian middle ear evolution.

Authors:  Neal Anthwal; Daniel J Urban; Zhe Xi Luo; Karen E Sears; Abigail S Tucker
Journal:  Nat Ecol Evol       Date:  2017-03-06       Impact factor: 15.460

Review 6.  Regulation of Embryonic and Postnatal Development by the CSF-1 Receptor.

Authors:  Violeta Chitu; E Richard Stanley
Journal:  Curr Top Dev Biol       Date:  2016-12-01       Impact factor: 4.897

7.  Activin A inhibits RANKL-mediated osteoclast formation, movement and function in murine bone marrow macrophage cultures.

Authors:  Tristan W Fowler; Archana Kamalakar; Nisreen S Akel; Richard C Kurten; Larry J Suva; Dana Gaddy
Journal:  J Cell Sci       Date:  2015-01-20       Impact factor: 5.285

8.  New roles of osteoblasts involved in osteoclast differentiation.

Authors:  Teruhito Yamashita; Naoyuki Takahashi; Nobuyuki Udagawa
Journal:  World J Orthop       Date:  2012-11-18

9.  Calreticulin inhibits inflammation-induced osteoclastogenesis and bone resorption.

Authors:  Charla R Fischer; Maya Mikami; Hiroshi Minematsu; Saqib Nizami; Heon Goo Lee; Danielle Stamer; Neel Patel; Do Yu Soung; Jung-Ho Back; Lee Song; Hicham Drissi; Francis Y Lee
Journal:  J Orthop Res       Date:  2017-07-18       Impact factor: 3.494

10.  Anti-Osteoporotic Effects of Commiphora Myrrha and Its Poly-Saccharide via Osteoclastogenesis Inhibition.

Authors:  Youn-Hwan Hwang; Ami Lee; Taesoo Kim; Seon-A Jang; Hyunil Ha
Journal:  Plants (Basel)       Date:  2021-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.